⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

LEGN

Legend Biotech Corporation

Healthcare · Biotechnology

19.27USD

+0.3700 (+1.96%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on LEGN.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End03/2026 Q1
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 19.27
P/E—
Dvd Ind Yld0.0%
P/B3.87
P/S3.3
Curr EV/T12M EBITDA-73.3
Mkt Cap (USD)3.7B
Curr EV (USD)3.0B
2)

Per Share Data

EPS T12M-1.36
DPS—
Bk Val Per Sh6.35
Rev/Sh6.15
Cash/Sh4.98
Curr Shares Out194.5M
FCF/Sh-0.63
3)

Cash Flow Analysis

P/CF-45.9
Curr P/FCF-32.4
CF/NI0.3
Dvd P/O—
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-7.2%
Eff Interest Rate7.6%
4)

Growth Potential

Dil EPS 1Y Gr-68.8%
Cap 1Y Gr-1.5%
BPS 1Y Gr-4.5%
R&D To Sales35.0%
Retention Rate—
Rev 1Y Gr64.0%
FCF 1Y Gr18.5%
Assets 1Y Gr3.8%
5)

Profitability

EBITDA-0.1B
EBIT-0.1B
Operating Margin-11.9%
Pretax Margin-20.8%
Net Margin-22.0%
ROA-15.6%
ROE-25.2%
ROC—
Asset Turnover0.71
6)

Structure

Current Ratio2.13
Quick Ratio2.88
Debt/Assets27.4%
Debt/Com Eq45.3%
Net Debt/EBITDA2.16
Tot Debt/Capital31.2%
Gross Margin55.0%
EBIT/Int Exp-6.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.